Latha Palaniappan, M.D., M.S.
Associate Scientist & Medical Director, Clinical Research
Outcomes and Clinical Research, Dr. Latha Palaniappan provides overall leadership of research to be undertaken in the department, helps recruit and mentor investigators, and ensures adherence to good research practices by all members of the department. She also builds research relationships and collaborations within the Palo Alto Medical Foundation’s Research Institute (PAMFRI), with PAMF clinicians and with colleagues outside of PAMF. As chair, she furthermore leverages access to PAMF’s database and patient population to foster new research opportunities for both members of the department and all of PAMFRI.
In this role, she leads the Disparities and Culture: Outcomes in Vitality Research Program (DISCOVeR) that investigates racial/ethnic health disparities in cardiometabolic disease risk, burden, screening, treatment and outcomes in multiethnic populations.
Dr. Palaniappan serves as a consulting associate professor at the Stanford University School of Medicine. She is also a graduate of Stanford's Clinical Epidemiology Masters program, funded by the Clinical Research Curriculum Award (K30). She is board certified in general Internal Medicine, augmented by further clinical training in Preventive Cardiology. She continues to devote a portion of her time to clinical work in Internal Medicine. She has received grants from the National Heart, Lung, and Blood Institute, the National Institutes of Health, the American Heart Association, the American Diabetes Association, and the National Institute of Diabetes and Digestive and Kidney Diseases to explore gender and ethnic differences in insulin metabolism as it affects the incidence of metabolic syndrome, diabetes and coronary heart disease.
She holds a bachelor’s degree in Biomedical Sciences and an M.D. from the University of Michigan, as well as a master’s degree in Clinical Epidemiology from Stanford University.
Bhalla V, Zhao B, Azar KM, Wang EJ, Choi S, Wong EC, Fortmann SP, Palaniappan LP. Racial/Ethnic Differences in the Prevalence of Proteinuric and Nonproteinuric Diabetic Kidney Disease.. Diabetes Care. 2012. [Epub ahead of print]
Baker FC, Sassoon SA, Kahan T, Palaniappan L, Nicholas CL, Trinder J, Colrain IM..Perceived Poor Sleep Quality in the Absence of Polysomnographic Sleep Disturbance in Women with Severe Premenstrual Syndrome.. Journal of Sleep Research. 2012.
Goyal D, Wang EJ, Shen J, Wong EC, Palaniappan LP.. Clinically Identified Postpartum Depression in Asian American Mothers. Journal of Obstetric, Gynecologic, and Neonatal Nursing: JOGNN / NAACOG. 2012;41(3):408-16
Holland AT, Palaniappan LP. Problems with the Collection and Interpretation of Asian-American Health Data: Omission, Aggregation, and Extrapolation. Ann Epidemiol. Jun 2012;22(6):397-405.
Anerjee D, Chung S, Wong EC, Wang EJ, Stafford RS, Palaniappan LP. Underdiagnosis of Hypertension Using Electronic Health Records. B Am J Hypertens.. 2012;25(1):97-102.
Koenig CJ, Dutta MJ, Kandula N, LP. "All of Those Things We Don't Eat": A Culture-Centered Approach to Dietary Health Meanings for Asian Indians Living in the United States. P. Health Communication. 2012;1(11).
Azar KM, Moreno MR, Wong EC, Shin JJ, Soto C, Palaniappan LP. Accuracy of Data Entry of Patient Race/Ethnicity/Ancestor and Preferred Spoken Language in an Ambulatory Care Setting: Accuracy of Data Entry of Patient R/E/A/L. Health Serv Res. Aug 24 2011.
Palaniappan LP, Muzaffar AL, Wang EJ, Wong EC, Orchard TJ. Shared medical appointments: promoting weight loss in a clinical setting. J Am Board Fam Med. 2011 May-Jun; 24 (3): 326-8
Palaniappan LP, Wong EC, Shin JJ, Fortmann SP, Lauderdale DS. Asian Americans have greater prevalence of metabolic syndrome despite lower body mass index . Int J Obes (Lond). 2011; 35 (3): 393-400
Dixit AA, Azar KM, Gardner CD, Palaniappan LP. Incorporation of whole, ancient grains into a modern Asian Indian diet to reduce the burden of chronic disease . Nutr Rev. 2011; 69 (8): 479-488
Palaniappan LP, Maxwell AE, Crespi CM, Wong EC, Shin J, Wang EJ. Population Colorectal Cancer Screening Estimates: Comparing Self-Report to Electronic Health Record Data in California. Int J Canc Prev. 2011; 4 (1)
Banerjee D, Wong EC, Shin J, Fortmann SP, Palaniappan L. Racial and Ethnic Variation in Lipoprotein (a) Levels among Asian Indian and Chinese Patients . J Lipids. 2011: 2011 291954
Holland AT, Wong EC, Lauderdale DS, Palaniappan LP. Spectrum of cardiovascular diseases in Asian-American racial/ethnic subgroups . Ann Epidemiol. 2011; 21 (8): 608-14
Wang EJ, Wong EC, Dixit AA, Fortmann SP, Linde RB, Palaniappan LP. Type 2 diabetes: Identifying high risk Asian American subgroups in a clinical population. Diabetes Res Clin Pract. 2011; 93 (2): 248-54
Palaniappan LP, Araneta MR, Assimes TL, Barrett-Connor EL, Carnethon MR, Criqui MH, Fung GL, Narayan KM, Patel H, Taylor-Piliae RE, Wilson PW, Wong ND. Call to action: cardiovascular disease in Asian Americans: a science advisory from the American Heart Association . Circulation. 2010; 122 (12): 1242-52
Chung S, Palaniappan L, Wong E, Rubin H, Luft H. Does the frequency of pay-for-performance payment matter? — Experience from a randomized trial . Health Serv Res. 2010; 45 (2): 553-64
Chung S, Palaniappan LP, Trujillo LM, Rubin HR, Luft HS.Effect of physician-specific pay-for-performance incentives in a large group practice . Am J Manag Care. 2010; 16 (2): e35-42
Palaniappan L, Mukherjea A, Holland A, Ivey SL.Leading causes of mortality of Asian Indians in California. Ethn Dis. 2010; 20 (1): 53-7
Narayan KM, Aviles-Santa L, Oza-Frank R, Pandey M, Curb JD, McNeely M, Araneta MR, Palaniappan L, Rajpathak S, Barrett-Connor E. Report of a National Heart, Lung, And Blood Institute Workshop: heterogeneity in cardiometabolic risk in Asian Americans In the U.S. Opportunities for research. J Am Coll Cardiol. 2010; 55 (10): 966-73
Wong EC, Palaniappan LP, Lauderdale DS. Using name lists to infer Asian racial/ethnic subgroups in the healthcare setting. Med Care. 2010; 48 (6): 540-6